FDA issued a CRL to Pharming’s Joenja child use filing, citing dosing concerns in lower-weight kids and testing issues.
Importance Rank:
1
FDA issued a CRL to Pharming’s Joenja child use filing, citing dosing concerns in lower-weight kids and testing issues.
The UCW Newswire : Financial, Business and Tech NewsCopyright © Louis Velazquez. All Rights Reserved.